Trial Outcomes & Findings for Assessment of Ability of 3D Fluorscopy in Aiding Accurate Syndesmotic Reduction Following Traumatic Ankle Injury (NCT NCT03163017)
NCT ID: NCT03163017
Last Updated: 2019-09-12
Results Overview
Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic reductions.
COMPLETED
NA
30 participants
Immediately at the time of 3D Fluoroscopy
2019-09-12
Participant Flow
Participant milestones
| Measure |
2D Fluoroscopy Then 3D Fluoroscopy
Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers et al (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic and fibular reductions. Both 2D and 3D Fluoroscopy will be performed using device "Ziehm Vision RFD 3D image-intensified fluoroscopic x-ray system".
|
|---|---|
|
Overall Study
STARTED
|
30
|
|
Overall Study
COMPLETED
|
30
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Assessment of Ability of 3D Fluorscopy in Aiding Accurate Syndesmotic Reduction Following Traumatic Ankle Injury
Baseline characteristics by cohort
| Measure |
2D Fluoroscopy Then 3D Fluoroscopy
n=30 Participants
Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers et al (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic and fibular reductions. Both 2D and 3D Fluoroscopy will be performed using device "Ziehm Vision RFD 3D image-intensified fluoroscopic x-ray system".
|
|---|---|
|
Age, Continuous
|
39 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
11 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
19 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black
|
10 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
12 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
5 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Unknown
|
2 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
30 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Immediately at the time of 3D FluoroscopyPatients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic reductions.
Outcome measures
| Measure |
2D Fluoroscopy Then 3D Fluoroscopy
n=30 Participants
Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers et al (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic and fibular reductions. Both 2D and 3D Fluoroscopy will be performed using device "Ziehm Vision RFD 3D image-intensified fluoroscopic x-ray system".
|
|---|---|
|
Number of Participants for Which the Surgeon Changed Reduction of Syndesmotic Reduction Because of Information Provided by 3D Fluoroscopy
|
14 Participants
|
SECONDARY outcome
Timeframe: Immediately at the time of 3D FluoroscopyPatients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess fibular fracture reductions.
Outcome measures
| Measure |
2D Fluoroscopy Then 3D Fluoroscopy
n=30 Participants
Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers et al (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic and fibular reductions. Both 2D and 3D Fluoroscopy will be performed using device "Ziehm Vision RFD 3D image-intensified fluoroscopic x-ray system".
|
|---|---|
|
Number of Participants for Which the Surgeon Changed Reduction of Fibular Fracture Reduction Because of Information Provided by 3D Fluoroscopy
|
0 Participants
|
SECONDARY outcome
Timeframe: 3 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 3 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 3 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 3 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 3 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 months after 3D FluoroscopyPopulation: Data was not collected for this outcome measure.
Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 1 day after 3D FluoroscopyMalreduction will be determined by comparing uninjured ankle to the injured ankle
Outcome measures
| Measure |
2D Fluoroscopy Then 3D Fluoroscopy
n=30 Participants
Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers et al (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic and fibular reductions. Both 2D and 3D Fluoroscopy will be performed using device "Ziehm Vision RFD 3D image-intensified fluoroscopic x-ray system".
|
|---|---|
|
Number of Participants With Syndesmotic Malreduction as Assessed by a Single Postoperative Bilateral CT Scan
|
3 Participants
|
Adverse Events
2D Fluoroscopy Then 3D Fluoroscopy
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Joshua Gary, MD
The University of Texas Health Science Center at Houston
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place